Abrexa Pharmaceuticals Receives $500,793 New Funding

  • Feed Type
  • Date
    9/8/2011
  • Company Name
    Abrexa Pharmaceuticals
  • Mailing Address
    12481 High Bluff Drive San Diego, CA 92130
  • Company Description
    Abrexa Pharmaceuticals is a stealth mode pharmaceutical development company.
  • Website
    Undisclosed
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $500,793
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. $742.60 of total amount sold is purchase price of common stock issued; $500,000 is purchase price of convertible promissory notes issued; and $50 is purchase price of warrants to purchase capital stock. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.